Table 1 Preferential practices regarding management of pediatric acute gastroenteritis
Preferential practices (>70%) | Total | Belgium | The Netherlands | Switzerland | France |
|---|---|---|---|---|---|
N = 68 | N = 10 | N = 7 | N = 14 | N = 37 | |
CI 95% | |||||
First-intention rehydration method | |||||
ORS oral route | 61 (90%) | 10 (100%) | 5 (71%) | 12 (86%) | 34 (92%) |
CI [80–96] | |||||
ORS pure | 62 (91%) | 10 (100%) | 6 (86%) | 13 (93%) | 33 (89%) |
CI [82–97] | |||||
Rehydration route in case of oral rehydration failure | |||||
Intra-venous route | 35 (51%) | 0 (0%) | 0 (0%) | 0 (0%) | 35 (95%) |
CI [39–64] | |||||
Nasogastric route (with ORS) | 28 (41%) | 8 (80%) | 7 (100%) | 12 (86%) | 1 (3%) |
CI [29–54] | |||||
Medication in case of oral rehydration failure | |||||
Ondansetron | 6 (9%) | 0 (0%) | 1 (14%) | 5 (36%) | 0 (0%) |
CI [3–18] | |||||
Racecadotril | 19 (28%) | 0 (0%) | 0 (0%) | 0 (0%) | 19 (51%) |
CI [18–40] | |||||
Laboratory tests in case of oral rehydration failure | |||||
Electrolytes | 49 (72%) | 8 (80%) | 3 (43%) | 4 (29%) | 34 (92%) |
CI [60–82] | |||||
Blood count | 28 (41%) | 6 (60%) | 2 (29%) | 1 (7%) | 19 (51%) |
CI [29–54] | |||||
C-reactive protein | 25 (37%) | 6 (60%) | 2 (29%) | 1 (7%) | 16 (43%) |
CI [25–49] | |||||
Stool virology | 20 (29%) | 5 (50%) | 2 (29%) | 1 (7%) | 12 (32%) |
CI [19–42] | |||||
Stool culture | 11 (16%) | 2 (20%) | 3 (43%) | 0 (0%) | 6 (16%) |
CI [8–27] |